End Stage Liver Disease [dsyn]    
Prevalence [qnco]    
Risk factor [qnco]    
clinical characteristics [clna]    
Cohort [popg]    
human hepatitis C virus [virs]    
immunodeficiency virus [virs]    
Co-infection [dsyn]    
Han [lang]    
chinese [lang]    
Introduction [hlca]    
combination therapies [topp]    
Liver [bpoc]    
Relate [orch]    
Mortalities [qnco]    
Leading [tmco]    
cause [ftcn]    
Non [ftcn]    
Aid [dsyn]    
Relate [orch]    
Death [orgf]    
Virus, Human Immunodeficiency [virs]    
infect [ftcn]    
patient [podg]    
Western [spco]    
Countries [geoa]    
Object [inpr]    
To [qlco]    
investigate [ftcn]    
Incidence [qnco]    
Mortalities [qnco]    
Risk factor [qnco]    
End Stage Liver Disease [dsyn]    
Virus, Human Immunodeficiency [virs]    
Hepatitis C virus [virs]    
Co-infection [dsyn]    
Former [tmco]    
Plasma donor [popg]    
Blood [tisu]    
Recipient [humn]    
Method [inpr]    
Retrospective Studies [resa]    
Conduct [inbe]    
Result [ftcn]    
human hepatitis C virus [virs]    
immunodeficiency virus [virs]    
Co-infection [dsyn]    
patient [podg]    
End Stage Liver Disease [dsyn]    
/40 [tmco]    
DI [orgf]    
Factor [ftcn]    
Associated [qlco]    
End Stage Liver Disease [dsyn]    
include [ftcn]    
Old age [fndg]    
baseline [bodm]    
odd ratio [qnco]    
+2 [qnco]    
greater [qnco]    
Equal [qlco]    
+2 [qnco]    
Upper Limit of Normal [qnco]    
End [spco]    
Follow-up [fndg]    
odd ratio [qnco]    
Hepatitis B Virus [virs]    
odd ratio [qnco]    
+2 [qnco]    
CDC [hcro]    
c stage [inpr]    
odd ratio [qnco]    
>5 [qnco]    
Duration [tmco]    
combination therapies [topp]    
greater [qnco]    
>5 [qnco]    
year [tmco]    
odd ratio [qnco]    
<3 [qnco]    
0.010" [qnco]    
CD4 [lbpr]    
Count [acty]    
greater [qnco]    
Equal [qlco]    
Cell [cell]    
<3 [qnco]    
End [spco]    
Follow-up [fndg]    
odd ratio [qnco]    
0.016" [qnco]    
Probabilities [qnco]    
End Stage Liver Disease [dsyn]    
human hepatitis C virus [virs]    
immunodeficiency virus [virs]    
Co-infection [dsyn]    
Blood [tisu]    
Recipient [humn]    
High [qlco]    
Former [tmco]    
Plasma donor [popg]    
Mortalities [qnco]    
High [qlco]    
human hepatitis C virus [virs]    
immunodeficiency virus [virs]    
Co-infection [dsyn]    
patient [podg]    
End Stage Liver Disease [dsyn]    
Without [qlco]    
End Stage Liver Disease [dsyn]    
Conclusion [idcn]    
combination therapies [topp]    
End Stage Liver Disease [dsyn]    
Common [qnco]    
human hepatitis C virus [virs]    
immunodeficiency virus [virs]    
Co-infection [dsyn]    
Han [lang]    
chinese [lang]    
patient [podg]    
Response [fndg]    
Reduced [qlco]    
*^patient [podg]    
Survival time [clna]    
[c] [qnco]    
SA [orch]    
Rights [qlco]    
Reservation [acty]    
